Biotech

All Articles

Former Seagen CEO unveils new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually offered to Pfizer in 2014 for ...

Ironwood produces additional bid for $1B GI medication along with brand-new subgroup data

.On the heels of a phase 3 succeed that neglected to make an impression on financiers, Ironwood Phar...

Novartis inks $150M package for autoimmune molecular adhesive

.Don't stop Monte Rosa Rehabs now. The Boston-based biotech is actually having a ball after signing ...

Jade takes exec staff along with Chinook vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings as...

Septerna goes public along with upsized offering of $288M

.Celebrating his firm's upsized initial public offering (IPO), Septerna chief executive officer Jeff...

AbbVie makes Richter wealthier, paying for $25M to create finding deal

.AbbVie has actually come back to the source of its own antipsychotic goliath Vraylar trying to find...

GenSight enters into final full weeks of money path as income stream slips by of reach

.GenSight Biologics is actually weeks off of lacking loan. Once more. The biotech just has sufficien...

AZ licenses discarded unusual condition medication to Monopar Therapies

.Monopar Therapies is recouping a drug coming from the scrap heap of AstraZeneca's uncommon illness ...

Arcus' new HIF-2a data in renal cancer hint at prospective edge over Merck's Welireg, experts state

.Along with brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of ...

Roche bets approximately $1B to broaden Dyno genetics treatment delivery contract

.After creating a genetics treatment collaboration with Dyno Rehabs in 2020, Roche is back for even ...